
Keiichiro SUZUKI | Specially Designated Professor | Osaka …
Keiichiro SUZUKI, Specially Designated Professor | Cited by 14,588 | of Osaka University, Osaka (Handai) | Read 369 publications | Contact Keiichiro SUZUKI
People | Institute for Advanced Co-Creation Studies / Osaka …
Keiichiro Suzuki, Ph.D. [email protected]. Education and Professional Experience
In vivo genome editing via CRISPR/Cas9 mediated homology ... - Nature
2016年11月16日 · Based on clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9) 3, 4 technology, here we devise a homology-independent targeted integration (HITI) strategy, which allows for...
HOME | Institute for Advanced Co-Creation Studies / Osaka …
2017年8月1日 · Keiichiro Suzuki laboratory has started at Osaka University. Our laboratory aims to develop novel genome-editing technologies which are suitable for clinical applications such as targeted gene therapy for inherited disease.
Precise in vivo genome editing via single homology arm donor …
Here, we describe a versatile in vivo gene knock-in methodology that enables the targeting of a broad range of mutations and cell types through the insertion of a minigene at an intron of the target gene locus using an intracellularly linearized single homology arm donor.
Keiichiro Suzuki - Research.com
Keiichiro Suzuki focuses on Genome editing, Computational biology, Induced pluripotent stem cell, Gene and Genetics. His Genome editing study incorporates themes from Embryonic stem cell, Nucleotide, DNA repair, Blastocyst and In vivo.
Keiichiro Suzuki | Inamori Foundation - 公益財団法人 稲盛財団
Graduate School of Engineering Science, Osaka University Professor *Profile is at the time of the award. Targeted genome editing via engineered nucleases is revolutionizing biomedical research and holds tremendous potential for clinical applications.
Research | Institute for Advanced Co-Creation Studies / Osaka ...
Our laboratory aims to develop novel genome-editing technologies which are suitable for clinical applications such as targeted gene therapy for inherited disease.
Keiichiro Suzuki - My portal - researchmap
Diverse regulatory pathways for IgA synthesis in the gut. Mucosal Immunol 2: 468-471, 2009. researchmap is an information sharing platform for the researchers. researchmap is provided by Japan Science and Technology Agency.
Keiichiro Suzuki - Semantic Scholar
Semantic Scholar profile for Keiichiro Suzuki, with 688 highly influential citations and 288 scientific research papers.
- 某些结果已被删除一些您可能无法访问的结果已被隐去。显示无法访问的结果